Cite
MLA Citation
Ya-Zhen Qin et al.. “PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes.” Leukemia & lymphoma, vol. 54, no. 7, n.d., pp. 1442–1449. http://access.bl.uk/ark:/81055/vdc_100031256742.0x00001d